Literature DB >> 10669346

Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.

A J Simpson1, M D Smith, G J Weverling, Y Suputtamongkol, B J Angus, W Chaowagul, N J White, S J van Deventer, J M Prins.   

Abstract

Raised serum concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6, or IL-10 are associated with mortality in patients with sepsis, but it is not known whether elevated cytokine levels are independently predictive of mortality. Cytokine assays (TNF-alpha, IL-6, and IL-10) were performed on admission plasma samples from 172 adult Thai patients with severe melioidosis. Mortality was 31.4%. APACHE II score; septicemia; plasma lactate; TNF-alpha, IL-6, and IL-10 concentrations; and IL-10/TNF-alpha and IL-6/IL-10 ratios were each associated with outcome (P</=.001 for all variables). Only the APACHE II score and either IL-6 or IL-10 concentration were independent predictors of mortality, as determined by use of multiple logistic regression (with cytokine concentrations and ratios entered separately). In a multivariate analysis, including both IL-6 and IL-10, the IL-10 concentration was no longer predictive. Therefore, APACHE II scores and either IL-6 or IL-10 concentration may be the most reliable parameters for stratification of patients in future studies of severe gram-negative sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669346     DOI: 10.1086/315271

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  Longitudinal profiling of plasma cytokines in melioidosis and their association with mortality: a prospective cohort study.

Authors:  T Kaewarpai; P Ekchariyawat; R Phunpang; S W Wright; A Dulsuk; B Moonmueangsan; C Morakot; E Thiansukhon; N P J Day; G Lertmemongkolchai; T E West; N Chantratita
Journal:  Clin Microbiol Infect       Date:  2019-11-07       Impact factor: 8.067

2.  Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.

Authors:  Jodie Morris; Natasha Williams; Catherine Rush; Brenda Govan; Kunwarjit Sangla; Robert Norton; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

3.  Short report: Predictors of severe disease in melioidosis patients in Kuala Lumpur, Malaysia.

Authors:  Ardita Dewi Roslani Mohd Roslani; Sun Tee Tay; Savithri D Puthucheary; Devi V Rukumani; I-Ching Sam
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

4.  Alteration of the phenotypic and pathogenic patterns of Burkholderia pseudomallei that persist in a soil environment.

Authors:  Yao-Shen Chen; Wun-Ju Shieh; Cynthia S Goldsmith; Maureen G Metcalfe; Patricia W Greer; Sherif R Zaki; Hsin-Hou Chang; Hao Chan; Ya-Lei Chen
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

5.  High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei.

Authors:  W Joost Wiersinga; Mark C Dessing; Piet A Kager; Allen C Cheng; Direk Limmathurotsakul; Nicholas P Day; Arjen M Dondorp; Tom van der Poll; Sharon J Peacock
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

6.  Impaired TLR5 functionality is associated with survival in melioidosis.

Authors:  T Eoin West; Narisara Chantratita; Wirongrong Chierakul; Direk Limmathurotsakul; Vanaporn Wuthiekanun; Nicolle D Myers; Mary J Emond; Mark M Wurfel; Thomas R Hawn; Sharon J Peacock; Shawn J Skerrett
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

7.  Pathogenesis of percutaneous infection of goats with Burkholderia pseudomallei: clinical, pathologic, and immunological responses in chronic melioidosis.

Authors:  Carl Soffler; Angela M Bosco-Lauth; Tawfik A Aboellail; Angela J Marolf; Richard A Bowen
Journal:  Int J Exp Pathol       Date:  2014-02-27       Impact factor: 1.925

8.  Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Authors:  Surasakdi Wongratanacheewin; Wannapa Kespichayawattana; Pakamas Intachote; Sathit Pichyangkul; Rasana W Sermswan; Arthur M Krieg; Stitaya Sirisinha
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Production of interleukin-27 by human neutrophils regulates their function during bacterial infection.

Authors:  Darawan Rinchai; Prasong Khaenam; Chidchamai Kewcharoenwong; Surachat Buddhisa; Rungnapa Pankla; Damien Chaussabel; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Eur J Immunol       Date:  2012-10-25       Impact factor: 5.532

10.  Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection.

Authors:  Siew Hoon Sim; Yichun Liu; Dongling Wang; Vidhya Novem; Suppiah Paramalingam Sivalingam; Tuck Weng Thong; Eng Eong Ooi; Gladys Tan
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.